Inovio Pharmaceuticals Inc
LSE:0A43
Inovio Pharmaceuticals Inc
LSE:0A43
Price:
1.315
USD
-1.13%
Market Closed
Market Cap:
$90.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Inovio Pharmaceuticals Inc
LSE:0A43
|
US |
|
U
|
United Therapeutics Corp
SWB:UTH
|
US |
|
B
|
BYD Co Ltd
XHAM:BY6
|
CN |
|
V
|
Vietjet Aviation JSC
VN:VJC
|
VN |
|
P
|
Petroleo Brasileiro SA Petrobras
SWB:PJX
|
BR |
|
I
|
Islandsbanki hf
ICEX:ISB
|
IS |
|
Yankuang Energy Group Co Ltd
F:YZCA
|
CN |
|
J
|
JAFCO Group Co Ltd
DUS:JAF
|
JP |
|
P
|
Primeenergy Resources Corp
F:PEJ
|
US |
|
A
|
Acadia Realty Trust
F:WX1
|
US |
|
A
|
Ares Commercial Real Estate Corp
F:41I
|
US |
|
F
|
Fresnillo PLC
DUS:FNL
|
MX |
|
Suzano SA
BOVESPA:SUZB3
|
BR |
|
A
|
Agnico Eagle Mines Ltd
DUS:AE9
|
CA |
Wall St Price Targets
0A43 Price Targets Summary
Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc
Wall Street analysts forecast 0A43 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0A43 is 6.846 USD with a low forecast of 1.805 USD and a high forecast of 13.553 USD.
Lowest Forecast
Price Target
1.805
USD
37% Upside
Average Forecast
Price Target
6.846
USD
421% Upside
Highest Forecast
Price Target
13.553
USD
931% Upside
Inovio Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0A43's stock price target?
Price Target
6.846
USD
6.846
USD
According to Wall Street analysts, the average 1-year price target for 0A43 is 6.846 USD with a low forecast of 1.805 USD and a high forecast of 13.553 USD.
What is the Revenue forecast for Inovio Pharmaceuticals Inc?
Projected CAGR
181%
181%
Over the last 14 years, the compound annual growth rate for Revenue has been -30%. The projected CAGR for the next 8 years is 181%.
